Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

计划入组 129 人 · 首次发布于 2022 年 4 月 12 日

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

计划入组 117 人 · 首次发布于 2022 年 11 月 3 日

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

计划入组 64 人 · 首次发布于 2021 年 11 月 3 日

TSC-201-B0702

TSC-203

TSC-202

EPILEPSY FOUNDATION OF AMERICA

United States

Korean Epilepsy Society

South Korea

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Cassava Sciences Appoints Joseph Hulihan as Chief Medical Officer to Lead Simufilam Development for TSC-Related Epilepsy

Filana Therapeutics' Simufilam Shows Dose-Dependent Seizure Reduction in Tuberous Sclerosis Complex Mouse Model

Aeovian Pharmaceuticals Secures $55 Million Series B to Advance First-in-Class mTORC1 Inhibitor for Rare Epilepsy